Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veit Rothhammer

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
Journal of Magnetic Resonance Imaging : JMRI|July 14, 2021
Longitudinal Sodium MRI of Multiple Sclerosis Lesions: Is there Added Value of Sodium Inversion Recovery MRIAngelika B Mennecke, Armin M Nagel, Konstantin Huhn, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 7, 2021
Aryl Hydrocarbon Receptor Activation in Astrocytes by Laquinimod Ameliorates Autoimmune Inflammation in the CNSVeit Rothhammer, Jessica E Kenison, Zahorong Li, et al.
Frontiers in Neurology|November 14, 2025
A multicenter, prospective cohort study on the anti-SARS-CoV-2 vaccination response in patients with multiple sclerosis in GermanyAchim Berthele, Clemens Gödel, Boris-Alexander Kallmann, et al.
Scientific Reports|December 5, 2025
Metabolomic and immunophenotypic signatures in cerebral amyloid angiopathy: a pilot studyThanos Tsaktanis, Arne Gessner, Steffen Pfeuffer, et al.
Human Mutation|September 15, 2004
Ten novel MSH2 and MLH1 germline mutations in families with HNPCCStefan Krüger, Andrea Bier, Jens Plaschke, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 5, 2025
Serum Levels of Aryl Hydrocarbon Receptor Plasma Agonist Activity Are Reduced in Patients With NMOSD and Correlate With Disease ActivityThanos Tsaktanis, Leander Ammon, Lena Lößlein, et al.
The New England Journal of Medicine|July 13, 2012
Potassium channel KIR4.1 as an immune target in multiple sclerosisRajneesh Srivastava, Muhammad Aslam, Sudhakar Reddy Kalluri, et al.
JCI Insight|April 8, 2022
Intranasal delivery of a small-molecule ErbB inhibitor promotes recovery from acute and late-stage CNS inflammationMathias Linnerbauer, Lena Lößlein, Oliver Vandrey, et al.
Magnetic Resonance Imaging|December 15, 2021
Direct imaging of white matter ultrashort T<sub>2</sub><sup>∗</sup> components at 7 TeslaMax Müller, Nico Egger, Stefan Sommer, et al.
Neurology|March 22, 2022
Simplified Edinburgh CT Criteria for Identification of Lobar Intracerebral Hemorrhage Associated With Cerebral Amyloid AngiopathyJochen A Sembill, Michael Knott, Mingming Xu, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Journal of Magnetic Resonance Imaging : JMRI|July 14, 2021
Longitudinal Sodium MRI of Multiple Sclerosis Lesions: Is there Added Value of Sodium Inversion Recovery MRIAngelika B Mennecke, Armin M Nagel, Konstantin Huhn, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 7, 2021
Aryl Hydrocarbon Receptor Activation in Astrocytes by Laquinimod Ameliorates Autoimmune Inflammation in the CNSVeit Rothhammer, Jessica E Kenison, Zahorong Li, et al.
Frontiers in Neurology|November 14, 2025
A multicenter, prospective cohort study on the anti-SARS-CoV-2 vaccination response in patients with multiple sclerosis in GermanyAchim Berthele, Clemens Gödel, Boris-Alexander Kallmann, et al.
Scientific Reports|December 5, 2025
Metabolomic and immunophenotypic signatures in cerebral amyloid angiopathy: a pilot studyThanos Tsaktanis, Arne Gessner, Steffen Pfeuffer, et al.
Human Mutation|September 15, 2004
Ten novel MSH2 and MLH1 germline mutations in families with HNPCCStefan Krüger, Andrea Bier, Jens Plaschke, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 5, 2025
Serum Levels of Aryl Hydrocarbon Receptor Plasma Agonist Activity Are Reduced in Patients With NMOSD and Correlate With Disease ActivityThanos Tsaktanis, Leander Ammon, Lena Lößlein, et al.
The New England Journal of Medicine|July 13, 2012
Potassium channel KIR4.1 as an immune target in multiple sclerosisRajneesh Srivastava, Muhammad Aslam, Sudhakar Reddy Kalluri, et al.
JCI Insight|April 8, 2022
Intranasal delivery of a small-molecule ErbB inhibitor promotes recovery from acute and late-stage CNS inflammationMathias Linnerbauer, Lena Lößlein, Oliver Vandrey, et al.
Magnetic Resonance Imaging|December 15, 2021
Direct imaging of white matter ultrashort T<sub>2</sub><sup>∗</sup> components at 7 TeslaMax Müller, Nico Egger, Stefan Sommer, et al.
Neurology|March 22, 2022
Simplified Edinburgh CT Criteria for Identification of Lobar Intracerebral Hemorrhage Associated With Cerebral Amyloid AngiopathyJochen A Sembill, Michael Knott, Mingming Xu, et al.
Pageof 9